FROM ALZHEIMER’S TREATMENT AND BLOOD TESTS, TO PREVENTION, BRAIN AGING, AND AI-POWERED DISCOVERY
Randall Bateman (USA)
FLUID BIOMARKERS FOR TAU PATHOPHYSIOLOGY IN ALZHEIMER'S DISEASE—WHAT DO THEY REFLECT AND WHAT CAN THEY BE USED FOR?
Henrik Zetterberg (Sweden)
MULTIMODAL BIOMARKER FOR PREVENTION TRIALS IN PD
Brit Mollenhauer (Germany)
ERIC N. BIRCH MEMORIAL LECTURE - MOLECULAR PATHOLOGY OF LEWY BODY DISEASES
Bradley Hyman (USA)
CAN GENETICS CRACK NEURODEGENERATION? FROM DISCOVERY TO DISEASE MODIFICATION?
Rosa Rademakers (Belgium)
THE ROLE OF VASCULAR DYSFUNCTION IN NEURODEGENERATION
Costantino Iadecola (USA)
HOW DO BRAIN MACROPHAGES SHAPE COGNITIVE RESILIENCE AND VULNERABILITY IN AGING AND DISEASE?
Beth Stevens (USA)